Tryptophan metabolism in Haemophilus persistence and formation of intracellular communities

嗜血杆菌持久性和细胞内群落形成中的色氨酸代谢

基本信息

  • 批准号:
    10408174
  • 负责人:
  • 金额:
    $ 19.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-05-20 至 2024-04-30
  • 项目状态:
    已结题

项目摘要

Abstract Infections caused by nontypeable Haemophilus influenzae (NTHI) strains represent a major cause of otitis media (OM), exacerbations of chronic obstructive pulmonary disease (COPD), and bacterial sinusitis. Furthermore, NTHI causes chronic, treatment-refractory diseases, in part by forming intracellular bacterial communities (IBCs) within epithelial cells that provide a refuge from both the host immune system, and from clinical interventions. The bacterial and host elements that impact NTHI persistence and recurrence of OM are not completely understood. Therefore, the delineation of host-pathogen interactions and metabolic influences that lead to OM- derived sequelae will inform novel therapeutic approaches. Our prior studies revealed a significant increase in all tryptophan biosynthetic pathway proteins during biofilm growth of a persistent isolate of NTHI. This isolate also demonstrated a significant increase in IBC formation during experimental OM. Critical to host-pathogen interactions is modulation of tryptophan levels. Tryptophan biosynthesis promotes intracellular survival of other pathogens and degradation of host tryptophan limits bacterial growth. In this study, we will delineate the contribution of tryptophan metabolism to NTHI pathogenesis during OM. Our central hypothesis is that NTHI adaptation to nutrient stress enhances invasion, IBC formation, persistence and recurrence. Our published studies indicate that multiple aspects of metabolism contribute to NTHI IBC formation and persistence. Our approach is to Determine the contribution of tryptophan metabolism in NTHI persistence and IBC formation (Aim 1). We hypothesize that bacterial adaptation to nutrient limitation modulates NTHI tryptophan biosynthesis that directly impacts pathogenesis and persistence. We will also evaluate the efficacy of interference with tryptophan biosynthesis as a novel therapeutic target (Aim 2). We hypothesize that prevention of invasion of NTHI into epithelial cells will promote bacterial clearance and thereby reduce the potential for recurrence of OM. Our studies will reveal mechanisms of tryptophan acquisition on NTHI behaviors that correlate with host responses during OM. Exploitation of these pathways to mitigate IBC development will provide a platform to continue to develop combinatorial treatments that target both the extracellular and intracellular populations of NTHI as an advanced therapeutic option to treat clinical disease.
摘要 由非分型流感嗜血杆菌(NTHI)菌株引起的感染是中耳炎的主要原因 慢性阻塞性肺疾病(COPD)的加重,以及细菌性鼻窦炎。此外, NTHI导致慢性难治性疾病,部分原因是通过形成细胞内细菌群落(IBCs) 在上皮细胞内,提供了躲避宿主免疫系统和临床干预的避难所。 影响OM NTHI持久性和复发的细菌和宿主因素并不完全 明白了。因此,描述导致OM的宿主-病原体相互作用和代谢影响- 衍生的后遗症将为新的治疗方法提供依据。我们之前的研究表明, NTHI持久分离物生物膜生长过程中的所有色氨酸生物合成途径蛋白。这株病毒 还显示在实验性OM期间IBC的形成显著增加。对寄主病原体至关重要 相互作用是色氨酸水平的调节。色氨酸生物合成促进其他生物细胞内存活 病原体和宿主色氨酸的降解限制了细菌的生长。在这项研究中,我们将描绘出 色氨酸代谢在OM时NTHI发病机制中的作用。我们的中心假设是NTHI 对营养胁迫的适应增强了入侵、IBC的形成、持久性和复发。我们出版的 研究表明,新陈代谢的多个方面有助于NTHI IBC的形成和持续。我们的 方法是确定色氨酸代谢在NTHI持久性和IBC中的贡献 编队(目标1)。我们假设细菌对营养限制的适应调节NTHI色氨酸 直接影响致病机理和持久性的生物合成。我们还将评估 干扰色氨酸生物合成作为新的治疗靶点(目标2)。我们假设 防止NTHI侵入上皮细胞将促进细菌清除,从而减少 OM复发的可能性。我们的研究将揭示色氨酸获得对NTHI行为的作用机制 这与OM期间的寄主反应有关。利用这些途径来缓解IBC的发展将 为继续开发针对细胞外和细胞外的联合治疗提供平台 NTHI的细胞内群体作为治疗临床疾病的高级治疗选择。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kevin M Mason其他文献

Kevin M Mason的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kevin M Mason', 18)}}的其他基金

A novel multifunctional role of diverse substrate binding and import by the Haemophilus Sap transporter
嗜血杆菌汁液转运蛋白多种底物结合和输入的新型多功能作用
  • 批准号:
    10092919
  • 财政年份:
    2019
  • 资助金额:
    $ 19.25万
  • 项目类别:
A novel multifunctional role of diverse substrate binding and import by the Haemophilus Sap transporter
嗜血杆菌汁液转运蛋白多种底物结合和输入的新型多功能作用
  • 批准号:
    9882943
  • 财政年份:
    2019
  • 资助金额:
    $ 19.25万
  • 项目类别:
A novel multifunctional role of diverse substrate binding and import by the Haemophilus Sap transporter
嗜血杆菌汁液转运蛋白多种底物结合和输入的新型多功能作用
  • 批准号:
    10343697
  • 财政年份:
    2019
  • 资助金额:
    $ 19.25万
  • 项目类别:
A novel multifunctional role of diverse substrate binding and import by the Haemophilus Sap transporter
嗜血杆菌汁液转运蛋白多种底物结合和输入的新型多功能作用
  • 批准号:
    10570899
  • 财政年份:
    2019
  • 资助金额:
    $ 19.25万
  • 项目类别:
The NTHI Sap Transporter: A Mechanism of Antimicrobial Peptide Resistance
NTHI 汁液转运蛋白:抗菌肽耐药性机制
  • 批准号:
    7314376
  • 财政年份:
    2007
  • 资助金额:
    $ 19.25万
  • 项目类别:
The NTHI Sap Transporter: A Mechanism of Antimicrobial Peptide Resistance
NTHI 汁液转运蛋白:抗菌肽耐药性机制
  • 批准号:
    7481172
  • 财政年份:
    2007
  • 资助金额:
    $ 19.25万
  • 项目类别:
Expression of sap Operon in NTHI-induced Otitis Media
NTHI诱导的中耳炎中SAP操纵子的表达
  • 批准号:
    6936560
  • 财政年份:
    2003
  • 资助金额:
    $ 19.25万
  • 项目类别:
Expression of sap Operon in NTHI-induced Otitis Media
NTHI诱导的中耳炎中SAP操纵子的表达
  • 批准号:
    6778272
  • 财政年份:
    2003
  • 资助金额:
    $ 19.25万
  • 项目类别:
Expression of sap Operon in NTHI-induced Otitis Media
NTHI诱导的中耳炎中SAP操纵子的表达
  • 批准号:
    6692403
  • 财政年份:
    2003
  • 资助金额:
    $ 19.25万
  • 项目类别:

相似海外基金

Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
  • 批准号:
    10590611
  • 财政年份:
    2022
  • 资助金额:
    $ 19.25万
  • 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中的骨-脂肪相互作用
  • 批准号:
    10706006
  • 财政年份:
    2022
  • 资助金额:
    $ 19.25万
  • 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
  • 批准号:
    10368975
  • 财政年份:
    2021
  • 资助金额:
    $ 19.25万
  • 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
  • 批准号:
    10365254
  • 财政年份:
    2021
  • 资助金额:
    $ 19.25万
  • 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
  • 批准号:
    10202896
  • 财政年份:
    2021
  • 资助金额:
    $ 19.25万
  • 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
  • 批准号:
    10531570
  • 财政年份:
    2021
  • 资助金额:
    $ 19.25万
  • 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
  • 批准号:
    10541847
  • 财政年份:
    2019
  • 资助金额:
    $ 19.25万
  • 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
  • 批准号:
    10319573
  • 财政年份:
    2019
  • 资助金额:
    $ 19.25万
  • 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
  • 批准号:
    10062790
  • 财政年份:
    2019
  • 资助金额:
    $ 19.25万
  • 项目类别:
Promotion of NAD+ anabolism to promote lifespan
促进NAD合成代谢以延长寿命
  • 批准号:
    DE170100628
  • 财政年份:
    2017
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Discovery Early Career Researcher Award
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了